Treatment of donor sites using a non cultured autologous cell suspension: A randomized controlled trial

Treatment of donor sites using a non cultured autologous cell suspension: A randomized controlled trial - a non cultured autologous cell suspension treated donor sites

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000015000

Enrollment

106

Registered

2014-09-10

Start date

2014-09-10

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

people who had donor site after skin grafted

Interventions

ReCell group control group

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients who required skin grafting and donor site covered.

Exclusion criteria

Exclusion criteria: Exclusion criteria consisted in the presence of pre-existing local and systemic bacterial infections, pre-existing medical conditions that would interfere with wound healing (diabetes, malignancy, autoimmune disease), renal failure (glomerular filtration rate inferior to 60 ml/min), medications that could interfere with wound healing (corticosteroids), hypersensitivity to Trypsin or Hartmann&#39;s solution, a high anesthesiology risk that necessarily postponed surgery.

Design outcomes

Primary

Measure	Time frame
healing time	—

Countries

Asia(except Japan)

Contacts

Public ContactHu Zhi-Cheng

The First Affiliated Hospital of Sun Yat-sen University Department of Burn Surgery

willway128@163.com86-20-87755766-8235

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026